SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients

Kei Miyoshi, Norihiro Sato, Kenoki Ohuchida, Kazuhiro Mizumoto, Masao Tanaka

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Secreted protein acidic and rich in cysteine (SPARC) is a protein which governs diverse cellular functions and matrix remodeling systems. It was reported that SPARC expression of peritumoral fibroblasts was correlated with poor prognosis in resectable pancreatic cancer patients in immunohistochemical analysis. However, the significance of SPARC mRNA expression in pancreatic adenocarcinoma remains unclear. Materials and Methods: SPARC mRNA expression was evaluated in 104 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma patients with macro-dissection technique. Results: High SPARC mRNA expression was associated with a poorer prognosis than low SPARC. In univariate Cox's proportion hazard model, depth of tumor invasion, lymph node metastasis, histopathological tumor grade, lymphatic invasion, vascular invasion, surgical margin, no chemotherapy and high SPARC expression were significant prognostic factors. In multivariate analysis, histopathological tumor grade, surgical margin, no chemotherapy and high SPARC expression were independent significant prognostic factors. Conclusion: SPARC mRNA expression is a prognostic marker for pancreatic adenocarcinoma patients.

Original languageEnglish
Pages (from-to)867-872
Number of pages6
JournalAnticancer research
Volume30
Issue number3
Publication statusPublished - Mar 1 2010

Fingerprint

Cysteine
Adenocarcinoma
Messenger RNA
Proteins
Drug Therapy
Neoplasms
Pancreatic Neoplasms
Proportional Hazards Models
Paraffin
Formaldehyde
Blood Vessels
Dissection
Multivariate Analysis
Fibroblasts
Lymph Nodes
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients. / Miyoshi, Kei; Sato, Norihiro; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Tanaka, Masao.

In: Anticancer research, Vol. 30, No. 3, 01.03.2010, p. 867-872.

Research output: Contribution to journalArticle

@article{50fe7ee78f794c0cb3070259ddc46f37,
title = "SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients",
abstract = "Background: Secreted protein acidic and rich in cysteine (SPARC) is a protein which governs diverse cellular functions and matrix remodeling systems. It was reported that SPARC expression of peritumoral fibroblasts was correlated with poor prognosis in resectable pancreatic cancer patients in immunohistochemical analysis. However, the significance of SPARC mRNA expression in pancreatic adenocarcinoma remains unclear. Materials and Methods: SPARC mRNA expression was evaluated in 104 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma patients with macro-dissection technique. Results: High SPARC mRNA expression was associated with a poorer prognosis than low SPARC. In univariate Cox's proportion hazard model, depth of tumor invasion, lymph node metastasis, histopathological tumor grade, lymphatic invasion, vascular invasion, surgical margin, no chemotherapy and high SPARC expression were significant prognostic factors. In multivariate analysis, histopathological tumor grade, surgical margin, no chemotherapy and high SPARC expression were independent significant prognostic factors. Conclusion: SPARC mRNA expression is a prognostic marker for pancreatic adenocarcinoma patients.",
author = "Kei Miyoshi and Norihiro Sato and Kenoki Ohuchida and Kazuhiro Mizumoto and Masao Tanaka",
year = "2010",
month = "3",
day = "1",
language = "English",
volume = "30",
pages = "867--872",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients

AU - Miyoshi, Kei

AU - Sato, Norihiro

AU - Ohuchida, Kenoki

AU - Mizumoto, Kazuhiro

AU - Tanaka, Masao

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Background: Secreted protein acidic and rich in cysteine (SPARC) is a protein which governs diverse cellular functions and matrix remodeling systems. It was reported that SPARC expression of peritumoral fibroblasts was correlated with poor prognosis in resectable pancreatic cancer patients in immunohistochemical analysis. However, the significance of SPARC mRNA expression in pancreatic adenocarcinoma remains unclear. Materials and Methods: SPARC mRNA expression was evaluated in 104 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma patients with macro-dissection technique. Results: High SPARC mRNA expression was associated with a poorer prognosis than low SPARC. In univariate Cox's proportion hazard model, depth of tumor invasion, lymph node metastasis, histopathological tumor grade, lymphatic invasion, vascular invasion, surgical margin, no chemotherapy and high SPARC expression were significant prognostic factors. In multivariate analysis, histopathological tumor grade, surgical margin, no chemotherapy and high SPARC expression were independent significant prognostic factors. Conclusion: SPARC mRNA expression is a prognostic marker for pancreatic adenocarcinoma patients.

AB - Background: Secreted protein acidic and rich in cysteine (SPARC) is a protein which governs diverse cellular functions and matrix remodeling systems. It was reported that SPARC expression of peritumoral fibroblasts was correlated with poor prognosis in resectable pancreatic cancer patients in immunohistochemical analysis. However, the significance of SPARC mRNA expression in pancreatic adenocarcinoma remains unclear. Materials and Methods: SPARC mRNA expression was evaluated in 104 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma patients with macro-dissection technique. Results: High SPARC mRNA expression was associated with a poorer prognosis than low SPARC. In univariate Cox's proportion hazard model, depth of tumor invasion, lymph node metastasis, histopathological tumor grade, lymphatic invasion, vascular invasion, surgical margin, no chemotherapy and high SPARC expression were significant prognostic factors. In multivariate analysis, histopathological tumor grade, surgical margin, no chemotherapy and high SPARC expression were independent significant prognostic factors. Conclusion: SPARC mRNA expression is a prognostic marker for pancreatic adenocarcinoma patients.

UR - http://www.scopus.com/inward/record.url?scp=77951050647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951050647&partnerID=8YFLogxK

M3 - Article

C2 - 20393008

AN - SCOPUS:77951050647

VL - 30

SP - 867

EP - 872

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -